JRPMC Journal of Rangpur Medical College • Vol. 8 No. 1 (2023): March 2023 • Pages 72-75
Published: 2023-04-04 Open Access Case Report

Isoniazid-induced Encephalopathy in a Patient with Pott’s Disease with Chronic Kidney Disease: A Case Report

1.
Md Helal Miah
Assistant Professor Department of Medicine Rangpur Medical College, Rangpur
2.
Md Ahad Bakas
MD Resident Department of Medicine Rangpur Medical College, Rangpur
3.
Md Kamal Hossein
Assistant Registrar Department of Medicine Rangpur Medical College, Rangpur
4.
Tahmina Begum
MD, Resident Department of Medicine Rangpur Medical College, Rangpur
5.
Md Shafiul Alam
Associate Professor Department of Medicine Rangpur Medical College, Rangpur
6.
Md Jahangir Kabir
Assistant Professor Department of Medicine Rangpur Medical College, Rangpur
7.
Abu Said Md Rahenur Mondol
Assistant Professor Department of Medicine Rangpur Medical College, Rangpur
8.
Md Ruhul Amin Sarkar
Assistant Professor Department of Medicine Rangpur Medical College, Rangpur
9.
Md Mahfuj Ul Anwar
Assistant Professor Department of Medicine Rangpur Medical College, Rangpur
10.
Shah Md Sarwer Jahan
Professor Department of Medicine Rangpur Medical College, Rangpur
11.
Md Mahfuzer Rahman
Professor and Head Department of Medicine Rangpur Medical College, Rangpur

Abstract

We report an isoniazid-induced encephalopathy in a man with chronic renal failure. Drug-induced encephalopathy is a common side effect of many drugs. Isoniazid (INH), a first-line drug for tuberculosis, can cause encephalopathy in patients with chronic kidney disease (CKD). For Pott's disease of the thoracic spine, he received rifampicin, INH, pyrazinamide, and ethambutol with pyridoxine and prednisolone. But the patient is free of pyridoxine for two and a half months. Subsequently, after treatment, the patient experienced recurrent episodes of altered consciousness, irrelevant conversations, and disorientation. After ruling out other causes, isoniazid-induced encephalopathy was suspected and confirmed by improvement of symptoms after discontinuation of high-dose isoniazid and pyridoxine.

J Rang Med Col. March 2023; Vol. 8, No. 1:72-75

Keywords: Chronic kidney disease Isoniazid-induced encephalopathy Tuberculosis
Full-Text Downloads:
Open Access Article License